Thought leadership to move us forward

This transcript is from the 2025 LeadershIP Conference hosted at CSIS on April 1st, 2025. Watch the full video here. (DOWNLOAD) LeadershIP 2025 – Panel IV Transcript Panel Description: There are several legislative proposals on the table today affecting IP, antitrust, and competition. Is more (or less) needed to

This transcript is from the 2025 LeadershIP Conference hosted at CSIS on April 1st, 2025. Watch the full video here. (DOWNLOAD) LeadershIP 2025 – Panel III Transcript Panel Description: The Artificial Intelligence revolution has raised key questions that society has yet to answer, from pending litigation over training data

This transcript is from the 2025 LeadershIP Conference hosted at CSIS on April 1st, 2025. Watch the full video here. (DOWNLOAD) LeadershIP 2025 – Keynote II Transcript Speaker Tonya L. Combs, Sr. Vice President – General Patent Counsel, Eli Lilly and Company

This transcript is from the 2025 LeadershIP Conference hosted at CSIS on April 1st, 2025. Watch the full video here. (DOWNLOAD) LeadershIP 2025 – Panel II Transcript Panel Description: As the world becomes increasingly interconnected and reliant on cutting-edge technologies, the role of IP in fostering innovation and ensuring

This transcript is from the 2025 LeadershIP Conference hosted at CSIS on April 1st, 2025. Watch the full video here. (DOWNLOAD) LeadershIP 2025 – Panel I Transcript Panel Description: National and economic security priorities are inextricably linked to technological leadership. What can innovation, IP, and competition policies do to

This transcript is from the 2025 LeadershIP Conference hosted at CSIS on April 1st, 2025. Watch the full video here. (DOWNLOAD) LeadershIP 2025 – Opening Remarks and Keynote Transcript Speakers Dr. Kirti Gupta, Executive Director, LeadershIP; Senior Adviser, Renewing American Innovation, CSIS Navin Girishankar, President, Economic Security & Technology Department,

By Kirti Gupta, Andrei Iancu, Walter G. Copan, and Chris Borges This report was originally published on March 26th with CSIS. Download the full report here. Executive Summary The United States is undergoing a generational shift in how economic policy intersects with national security. Decades of globalization have exposed

By Sujai Shivakumar, Charles Wessner, and Julie Heng For years, China has played a leading role in manufacturing active pharmaceutical ingredients and generic drugs. While securing the supply chain for active pharmaceutical ingredients is increasingly recognized as a national security priority by policymakers, China’s growing role in biotechnological innovation has

By Julie Heng, Arrizka Faida, and Chris Borges In a globalized economy, businesses rely on rules protecting intellectual property (IP) to safeguard their ideas and products against counterfeiting, piracy, and theft and to forge international partnerships. To this end, the United States and its partners have long invested in a system of multilateral treaties and international